To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STXBP3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
323 supporting clones for gene STXBP3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC323482 brain .a 1 to 601 1 to 601   tiling clone,   601/601
(100 %)
2 diff
(99.7 %id)
DC325969 caudate nucleus .a 2 to 570 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
DC406890 thymus .a 3 to 558 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
DC329947 hippocampus .a 13 to 594 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DC373593 tongue .a 13 to 540 1 to 528       528/528
(100 %)
0 diff
(100 %id)
DC420337 uterus .a 13 to 581 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
CN409056 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 18 to 271 14 to 267       254/267
(95 %)
7 diff
(97.4 %id)
AL597280   .a 28 to 269 1 to 242       242/242
(100 %)
4 diff
(98.4 %id)
DC343906 thalamus .a 29 to 572 1 to 545       545/545
(100 %)
2 diff
(99.7 %id)
NM_007269.2   .a 29 to 2522 1 to 2494 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 2494/2494
(100 %)
0 diff
(100 %id)
DC327420 caudate nucleus .a 34 to 599 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DC330169 hippocampus .a 34 to 609 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
DC354898   .a 34 to 601 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
DC406374 thymus .a 34 to 596 1 to 565       565/565
(100 %)
4 diff
(99.3 %id)
DC412110 kidney, tumor tissue .a 34 to 570 1 to 541       541/541
(100 %)
6 diff
(98.9 %id)
DC420433 uterus .a 34 to 540 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
DC300019   .a 40 to 598 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
AL603036 human skeletal muscle .a 40 to 653 1 to 614       614/614
(100 %)
0 diff
(100 %id)
DC414376 trachea .a 40 to 635 1 to 600       600/600
(100 %)
5 diff
(99.2 %id)
AU127751   .a 41 to 642 2 to 603   capped   602/602
(100 %)
2 diff
(99.7 %id)
DC378633   .a 41 to 601 1 to 562       562/562
(100 %)
3 diff
(99.5 %id)
DC340933 thalamus .a 42 to 631 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
DC297243   .a 42 to 463 1 to 422       422/422
(100 %)
0 diff
(100 %id)
DC350293 brain .a 42 to 617 1 to 576       576/576
(100 %)
0 diff
(100 %id)
DC406305 thymus .a 42 to 611 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
DC318843 brain .a 44 to 612 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
CD623992   .a 44 to 420 30 to 403       374/403
(92 %)
8 diff
(98.1 %id)
AK290134 thalamus .a 45 to 1998 1 to 1954 exact     1954/1954
(100 %)
2 diff
(99.9 %id)
DC341103 thalamus .a 45 to 645 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
DB485295 hypothalamus .a 48 to 511 1 to 468       468/468
(100 %)
7 diff
(98.6 %id)
AK291322 tongue .a 49 to 2522 1 to 2474 E285D     2474/2474
(100 %)
5 diff
(99.8 %id)
AK223170 Human lung .a 50 to 2522 1 to 2473 F242I AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 2473/2473
(100 %)
5 diff
(99.8 %id)
DA763618 tongue .a 50 to 630 2 to 582   capped   581/584
(99 %)
3 diff
(99.5 %id)
DA031403   .a 51 to 603 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
BP283196 bone marrow .a 51 to 633 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
AU100125   .a 51 to 349 1 to 300       300/300
(100 %)
4 diff
(98.7 %id)
BP293280 lung .a 51 to 632 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
DA818091   .a 51 to 603 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
AU280796   .a 51 to 619 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
AK312910   .a 52 to 1882 1 to 1831 exact     1831/1831
(100 %)
2 diff
(99.9 %id)
DA060148 cerebellum .a 52 to 627 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA252911 caudate nucleus .a 52 to 624 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA279268 corpus callosum .a 52 to 630 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA282984 corpus callosum .a 52 to 589 2 to 541   capped   540/540
(100 %)
3 diff
(99.5 %id)
DA303442 hippocampus .a 52 to 639 2 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
DA310265 hippocampus .a 52 to 630 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA329333 hippocampus .a 52 to 460 2 to 412   capped   411/420
(97 %)
4 diff
(99.1 %id)
DA365972 subthalamic nucleus .a 52 to 589 2 to 540   capped   539/539
(100 %)
3 diff
(99.5 %id)
DA391160 thalamus .a 52 to 647 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
DA447845 tongue, tumor tissue .a 52 to 609 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
D63506 brain .a 52 to 2530 1 to 2478 E277G E433G C546G tiling clone, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 2478/2478
(100 %)
8 diff
(99.7 %id)
DA500471 brain .a 52 to 606 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
BG707444 brain, hypothalamus .a 52 to 711 1 to 658       658/658
(100 %)
6 diff
(99.1 %id)
BI667586 brain, hypothalamus .a 52 to 708 1 to 658       658/658
(100 %)
5 diff
(99.3 %id)
DA660178   .a 52 to 625 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA708813   .a 52 to 644 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DA716579   .a 52 to 585 30 to 565   capped   536/564
(95 %)
7 diff
(98.8 %id)
DA719905   .a 52 to 635 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
AU135230 placenta .a 52 to 815 2 to 773   capped Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 772/774
(99 %)
14 diff
(98.2 %id)
DA906326   .a 52 to 618 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
DN994449 brain, whole brain .a 52 to 700 1 to 649       649/651
(99 %)
11 diff
(98.4 %id)
DB206523 trachea .a 52 to 625 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB208825 trachea .a 52 to 688 2 to 639   capped   638/638
(100 %)
2 diff
(99.7 %id)
DA156271 amygdala .a 53 to 526 2 to 475   capped   474/474
(100 %)
2 diff
(99.6 %id)
DA250639 caudate nucleus .a 53 to 562 2 to 512   capped   511/511
(100 %)
2 diff
(99.7 %id)
DA296126 hippocampus .a 53 to 611 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA423738   .a 53 to 616 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA470779   .a 53 to 611 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AV715345   .a 53 to 712 1 to 658       658/719
(91 %)
19 diff
(97.4 %id)
DA475615   .a 53 to 627 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA649147   .a 53 to 607 2 to 560   capped   559/559
(100 %)
5 diff
(99.2 %id)
DA653249   .a 53 to 649 2 to 600   capped   599/599
(100 %)
4 diff
(99.4 %id)
DA883455   .a 53 to 624 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA965522 stomach .a 53 to 618 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
DA998763 breast, tumor tissue .a 53 to 618 2 to 569   capped   568/568
(100 %)
5 diff
(99.2 %id)
DB111786 thymus .a 53 to 586 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
BC047764 Testis, embryonal carcinoma .a 54 to 2522 1 to 2469 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 2469/2469
(100 %)
1 diff
(100.0 %id)
CN409059 embryonic stem cells, cell lines H1, H7, andH9 .a 54 to 788 13 to 749       737/754
(97 %)
9 diff
(98.9 %id)
DA155445 amygdala .a 55 to 603 13 to 563   capped   551/551
(100 %)
3 diff
(99.5 %id)
DA372336 thalamus .a 55 to 609 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DA479581   .a 55 to 612 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
BI918036 brain .a 55 to 690 1 to 635       635/635
(100 %)
2 diff
(99.7 %id)
TI_57242635   .a 55 to 690 32 to 666       635/666
(95 %)
8 diff
(98.8 %id)
BM463257 embryonal carcinoma, cell line, testis .a 56 to 857 15 to 821       807/1079
(74 %)
26 diff
(97.6 %id)
ES307487 beard hair, skin .a 57 to 299 1 to 242       242/242
(100 %)
1 diff
(99.6 %id)
TI_44343545   .a 57 to 708 93 to 745       653/745
(87 %)
7 diff
(99.1 %id)
BI834958 pooled pancreas and spleen .a 58 to 762 1 to 713       713/715
(99 %)
13 diff
(98.2 %id)
TI_57167117   .a 58 to 762 33 to 745       713/747
(95 %)
16 diff
(97.9 %id)
DB208217 trachea .a 58 to 562 2 to 507   capped   506/506
(100 %)
2 diff
(99.7 %id)
AL532766 adult brain, brain .a 61 to 1065 1 to 1001       1001/1001
(100 %)
26 diff
(97.5 %id)
BM459736 leiomyosarcoma, uterus .a 61 to 897 1 to 845       845/864
(97 %)
10 diff
(98.9 %id)
DA365847 subthalamic nucleus .a 65 to 638 2 to 577   capped   576/577
(99 %)
4 diff
(99.4 %id)
DA463329   .a 65 to 614 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
CV572204 cornea, eye .a 66 to 690 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
CN409058 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 68 to 732 13 to 679       667/679
(98 %)
8 diff
(98.9 %id)
BI254685 cervical carcinoma cell line, cervix .a 68 to 883 1 to 829       827/832
(99 %)
29 diff
(96.6 %id)
DA259409 caudate nucleus .a 70 to 635 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
CN409060 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 72 to 629 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
CA396894 eye, RPE/choroid .a 75 to 703 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
BC038099 testis .a 90 to 2522 1 to 2433 K104R L150R available from MGC, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 2433/2433
(100 %)
4 diff
(99.9 %id)
DA467479 cord Blood .a 93 to 667 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA552681   .a 93 to 658 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
AF032922   .a 98 to 2522 52 to 2476 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 2425/2476
(97 %)
6 diff
(99.8 %id)
EL733797 mixed .a 104 to 758 1 to 653       653/653
(100 %)
4 diff
(99.4 %id)
EL734538 mixed .a 104 to 728 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
TI_1948212581   .a 104 to 881 133 to 912       780/1397
(55 %)
20 diff
(98.6 %id)
TI_1948212582   .a 104 to 1064 123 to 1081       959/1241
(77 %)
25 diff
(98.0 %id)
TI_1948212864   .a 104 to 865 127 to 892       766/1446
(52 %)
15 diff
(99.0 %id)
TI_1948212865   .a 104 to 1009 126 to 1031       906/1255
(72 %)
16 diff
(98.8 %id)
TI_1948213144   .a 104 to 1002 129 to 1031       903/1372
(65 %)
32 diff
(97.7 %id)
TI_1948213145   .a 104 to 1062 127 to 1083   AAA   957/1248
(76 %)
34 diff
(97.3 %id)
TI_1948213428   .a 104 to 1006 125 to 1024       900/1256
(71 %)
20 diff
(98.5 %id)
CX873752 embryonic stem .a 108 to 905 1 to 798       798/798
(100 %)
0 diff
(100 %id)
AV661506 corresponding non cancerous liver tissue .a 111 to 691 1 to 581     Submitted on the opposite strand 581/581
(100 %)
0 diff
(100 %id)
AV694866 hepatocellular carcinoma .a 124 to 771 1 to 648       648/657
(98 %)
2 diff
(99.7 %id)
CN409055 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 129 to 628 1 to 500       500/500
(100 %)
0 diff
(100 %id)
DA030227   .a 182 to 676 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DA129499 alzheimer cortex .a 212 to 679 2 to 469   capped   468/468
(100 %)
0 diff
(100 %id)
DA296053 hippocampus .a 220 to 783 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BP276758 Kidney .a 232 to 787 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
DB173523 kidney, tumor tissue .a 259 to 852 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
BM450606 eye, retinoblastoma .a 268 to 788 1 to 525       525/1042
(50 %)
10 diff
(99.1 %id)
BU934653 mixed (pool of 40 RNAs) .a 323 to 1066 1 to 747       747/760
(98 %)
9 diff
(98.9 %id)
AL526646 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 409 to 1344 1 to 936       936/936
(100 %)
4 diff
(99.6 %id)
DB104282 thymus .a 427 to 993 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
N87584   .a 446 to 694 1 to 247       247/248
(99 %)
11 diff
(95.6 %id)
DA881966   .a 458 to 933 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
AI383990 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 480 to 914 435 to 1       435/435
(100 %)
0 diff
(100 %id)
BG387574 embryonal carcinoma, cell line, testis .a 503 to 1141 1 to 639       639/986
(64 %)
6 diff
(99.4 %id)
BG387573 embryonal carcinoma, cell line, testis .a 504 to 1132 1 to 632       632/968
(65 %)
3 diff
(99.7 %id)
CF619413 Pooled Chondrosarcoma Tumor cells .a 515 to 1067 90 to 643       556/1059
(52 %)
22 diff
(98.0 %id)
DA154470 amygdala .a 527 to 1097 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA176903 amygdala .a 572 to 1041 2 to 472   capped   471/471
(100 %)
1 diff
(99.8 %id)
DA141241 alzheimer cortex .a 606 to 1165 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BM835308 stomach .a 688 to 1331 1 to 644       644/644
(100 %)
0 diff
(100 %id)
BU935111 mixed (pool of 40 RNAs) .a 724 to 1427 1 to 704       704/704
(100 %)
3 diff
(99.6 %id)
CA455519 mixed (pool of 40 RNAs) .a 734 to 1044 1 to 311   AAA   311/311
(100 %)
1 diff
(99.7 %id)
BP353384   .a 767 to 1348 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CD623993   .a 822 to 1277 471 to 16       456/471
(96 %)
2 diff
(99.6 %id)
BG778750 adenocarcinoma, Prostate .a 823 to 1466 1 to 660       660/731
(90 %)
37 diff
(95.0 %id)
DB556041 hypothalamus .a 827 to 1291 1 to 466     Submitted on the opposite strand 466/466
(100 %)
9 diff
(98.1 %id)
CN409057 embryonic stem cells, DMSO-treated H9 cellline .a 840 to 1630 1 to 791       791/791
(100 %)
5 diff
(99.4 %id)
DR762625 embryonic stem .a 843 to 1626 1 to 784       784/784
(100 %)
0 diff
(100 %id)
CD107771 brain, Pituitary .a 844 to 1638 1 to 799       799/853
(93 %)
16 diff
(98.2 %id)
CD513479 brain, Pituitary .a 863 to 1638 1 to 777       777/863
(90 %)
3 diff
(99.7 %id)
AA166699   .a 899 to 1439 1 to 533       533/533
(100 %)
12 diff
(97.8 %id)
BX105547 whole brain .a 930 to 1459 1 to 530       530/538
(98 %)
3 diff
(99.5 %id)
R61138 whole brain .a 931 to 1353 1 to 427     Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 427/560
(76 %)
11 diff
(98.1 %id)
AW858824 colon .a 959 to 1090 52 to 183       132/183
(72 %)
6 diff
(96.8 %id)
D82658   .a 959 to 1109 1 to 151       151/151
(100 %)
0 diff
(100 %id)
BM479125 melanotic melanoma, skin .a 995 to 2065 1 to 1084   AAA   1084/1101
(98 %)
31 diff
(97.2 %id)
TI_1948213147   .a 1001 to 1891 1004 to 117       888/1224
(72 %)
21 diff
(98.3 %id)
TI_1948212866   .a 1002 to 1891 1007 to 119       889/1270
(70 %)
24 diff
(98.2 %id)
BG616389 embryonal carcinoma, testis .a 1003 to 1670 1 to 678       676/683
(98 %)
25 diff
(96.4 %id)
F07137 brain, total brain .a 1029 to 1337 1 to 309       309/309
(100 %)
2 diff
(99.4 %id)
R13734 whole brain .a 1030 to 1307 1 to 278       278/289
(96 %)
5 diff
(98.3 %id)
BQ231998 melanotic melanoma, skin .a 1039 to 1754 40 to 758       719/926
(77 %)
13 diff
(98.6 %id)
BF096109 uterus_tumor .a 1058 to 1358 304 to 2       307/319
(96 %)
8 diff
(97.5 %id)
BF096134 uterus_tumor .a 1058 to 1358 314 to 11       308/334
(92 %)
7 diff
(98.0 %id)
BF096227 uterus_tumor .a 1065 to 1358 307 to 11       301/327
(92 %)
8 diff
(97.6 %id)
TI_1948213429   .a 1065 to 1891 946 to 119       828/1246
(66 %)
14 diff
(98.9 %id)
BG531850 embryonal carcinoma, testis .a 1066 to 1663 1 to 599       599/913
(65 %)
11 diff
(98.8 %id)
TI_1948213430   .a 1070 to 1891 941 to 118       824/1273
(64 %)
11 diff
(99.2 %id)
TI_1948212867   .a 1074 to 1891 932 to 115       818/1266
(64 %)
13 diff
(99.0 %id)
BE888627 leiomyosarcoma, uterus .a 1078 to 1788 1 to 723       723/840
(86 %)
23 diff
(97.3 %id)
BG498204 adenocarcinoma, Prostate .a 1081 to 1773 1 to 695       695/867
(80 %)
19 diff
(97.9 %id)
CA405914 adipose .a 1096 to 1761 1 to 666       666/668
(99 %)
2 diff
(99.8 %id)
BG170614 hypernephroma, cell line, Kidney .a 1110 to 1887 1 to 767       769/984
(78 %)
35 diff
(96.5 %id)
TI_1948212584   .a 1125 to 1891 879 to 113       767/1265
(60 %)
18 diff
(98.6 %id)
TI_1948212583   .a 1134 to 1891 875 to 118       758/1278
(59 %)
16 diff
(98.8 %id)
BM129140 Islets of Langerhans, Pancreas .a 1142 to 1717 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
BM129676 Islets of Langerhans, Pancreas .a 1142 to 1717 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
AA173515   .a 1164 to 1520 1 to 358       358/358
(100 %)
2 diff
(99.5 %id)
BG536428 lung .a 1177 to 1878 1 to 690       690/897
(76 %)
18 diff
(98.0 %id)
BG505809 embryonal carcinoma, testis .a 1183 to 1875 1 to 712       710/797
(89 %)
31 diff
(96.2 %id)
DA021248   .a 1212 to 1756 14 to 558   capped   545/557
(97 %)
10 diff
(98.3 %id)
BE768813 prostate_tumor .a 1212 to 1549 340 to 3       338/346
(97 %)
2 diff
(99.5 %id)
TI_1948213146   .a 1212 to 1891 795 to 118       678/1280
(52 %)
8 diff
(99.4 %id)
BI335856 skin .a 1270 to 1511 1 to 242       242/242
(100 %)
0 diff
(100 %id)
BF126302 Liver .a 1281 to 1892 1 to 612       612/616
(99 %)
7 diff
(98.9 %id)
BE567702 bladder, carcinoma, cell line .a 1304 to 1946 1 to 645       645/758
(85 %)
17 diff
(97.8 %id)
BF687841 brain, glioblastoma .a 1304 to 1982 1 to 668       668/824
(81 %)
32 diff
(96.2 %id)
CB145933 Liver .a 1313 to 1746 1 to 434       434/434
(100 %)
1 diff
(99.8 %id)
BG495892 lung, mucoepidermoid carcinoma .a 1330 to 1920 1 to 632       559/925
(60 %)
51 diff
(94.5 %id)
EC525756 Prostate .a 1341 to 1451 1 to 114       114/114
(100 %)
9 diff
(92.2 %id)
BG495831 lung, mucoepidermoid carcinoma .a 1348 to 1919 11 to 580       570/580
(98 %)
11 diff
(98.2 %id)
T48215 fetal spleen, Spleen .a 1354 to 1633 1 to 282       282/364
(77 %)
7 diff
(98.1 %id)
BU567573 testis .a 1388 to 2204 1 to 819       819/819
(100 %)
12 diff
(98.6 %id)
AA344140 gall bladder .a 1400 to 1739 1 to 340       340/340
(100 %)
8 diff
(97.7 %id)
AW965096   .a 1401 to 2058 1 to 659       659/659
(100 %)
3 diff
(99.6 %id)
BM686092 eye, Retina Foveal and Macular .a 1414 to 1983 1 to 571     Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 571/571
(100 %)
4 diff
(99.3 %id)
CD104647 Pooled-Skin .a 1437 to 2141 1 to 714       714/722
(98 %)
14 diff
(98.1 %id)
BG573136 placenta .a 1458 to 2186 1 to 727       727/728
(99 %)
10 diff
(98.7 %id)
AL532727 adult brain, brain .a 1464 to 2507 1037 to 1       1037/1037
(100 %)
84 diff
(91.9 %id)
BF790543 muscle (skeletal) .a 1491 to 2123 1 to 625       625/627
(99 %)
13 diff
(98.0 %id)
EC486644 Prostate .a 1502 to 1594 1 to 91       91/97
(93 %)
5 diff
(94.9 %id)
BF207716 bladder, carcinoma, cell line .a 1511 to 2186 1 to 667       667/685
(97 %)
12 diff
(98.3 %id)
BF238341 bone marrow, from chronic myelogenous leukemia .a 1525 to 2088 1 to 563       563/563
(100 %)
8 diff
(98.6 %id)
BG253681 adenocarcinoma, cell line, Prostate .a 1545 to 2260 17 to 713       697/824
(84 %)
33 diff
(96.0 %id)
AL526622 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1558 to 2493 936 to 1       936/936
(100 %)
5 diff
(99.5 %id)
BG612653 embryonal carcinoma, testis .a 1578 to 2297 1 to 718       718/719
(99 %)
8 diff
(98.9 %id)
BU570929 testis .a 1585 to 2379 1 to 800       800/886
(90 %)
29 diff
(96.8 %id)
CD677585 eye, Trabecular meshwork .a 1610 to 2246 1 to 639       639/639
(100 %)
5 diff
(99.3 %id)
BQ344954 nervous_tumor .a 1636 to 1897 36 to 296       261/296
(88 %)
7 diff
(97.7 %id)
AW630812 2 pooled high-grade transitional celltumors, genitourinary tract .a 1672 to 2096 1 to 425   fully sequenced,   425/425
(100 %)
0 diff
(100 %id)
BE866611 bladder, carcinoma, cell line .a 1673 to 2239 1 to 562       562/688
(81 %)
18 diff
(97.4 %id)
BE009339 breast_normal .a 1691 to 1809 119 to 1     Submitted on the opposite strand 119/119
(100 %)
0 diff
(100 %id)
BM702931 eye, Retina Foveal and Macular .a 1705 to 2408 1 to 705       705/705
(100 %)
1 diff
(99.9 %id)
BY999696   .a 1717 to 2256 1 to 535     Submitted on the opposite strand 535/586
(91 %)
14 diff
(97.7 %id)
AA207077 germinal center B cell .a 1721 to 2247 6 to 532       527/533
(98 %)
6 diff
(98.9 %id)
BM129390 Islets of Langerhans, Pancreas .a 1943 to 2531 590 to 2       589/590
(99 %)
0 diff
(100 %id)
AU150218   .a 1964 to 2530 566 to 1       566/567
(99 %)
8 diff
(98.6 %id)
BM128876 Islets of Langerhans, Pancreas .a 1984 to 2531 549 to 2       548/549
(99 %)
0 diff
(100 %id)
BU726127 eye, Retina Foveal and Macular .a 2043 to 2530 505 to 18   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 488/488
(100 %)
0 diff
(100 %id)
AA167022   .a 2083 to 2530 448 to 1       448/589
(76 %)
4 diff
(99.4 %id)
AW627572 2 pooled high-grade transitional celltumors, genitourinary tract .a 2083 to 2522 440 to 1   fully sequenced,   440/440
(100 %)
0 diff
(100 %id)
T48216 fetal spleen, Spleen .a 2099 to 2531 448 to 1       448/452
(99 %)
23 diff
(95.0 %id)
AU155909 placenta .a 2110 to 2530 426 to 1     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 426/429
(99 %)
10 diff
(97.7 %id)
AA173425   .a 2165 to 2531 381 to 7       375/381
(98 %)
0 diff
(100 %id)
R20770 whole brain .a 2229 to 2528 303 to 3       301/303
(99 %)
0 diff
(100 %id)
Z40240 brain, total brain .a 2299 to 2522 223 to 1       223/223
(100 %)
1 diff
(99.6 %id)
R61856 whole brain .a 2338 to 2530 216 to 24   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 193/193
(100 %)
0 diff
(100 %id)
CR606910 adult brain .b 1 to 2447 4 to 2450 exact tiling clone,   2450/2450
(100 %)
0 diff
(100 %id)
BU183889 melanotic melanoma, skin .b 4 to 846 12 to 857       846/888
(95 %)
15 diff
(98.4 %id)
BU507672 leiomyosarcoma, uterus .b 4 to 852 1 to 851   AAA   851/864
(98 %)
11 diff
(98.8 %id)
BM126917 Islets of Langerhans, Pancreas .b 23 to 570 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
TI_1948213427   .b 40 to 848 130 to 940       811/1358
(59 %)
19 diff
(98.7 %id)
BU188939 melanotic melanoma, skin .b 42 to 848 12 to 824       813/837
(97 %)
16 diff
(98.1 %id)
TI_149279816   .b 1722 to 2470 860 to 109   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 752/1117
(67 %)
27 diff
(97.6 %id)
FN153035 breast carcinoma .b 1727 to 1843 120 to 1     Submitted on the opposite strand 120/129
(93 %)
5 diff
(96.2 %id)
BG290972 bladder, transitional cell papilloma, cell line .b 1727 to 2450 10 to 726       717/907
(79 %)
32 diff
(96.5 %id)
FN096717 breast carcinoma .b 1737 to 1833 98 to 2     Submitted on the opposite strand 97/99
(97 %)
0 diff
(100 %id)
FN076802 breast carcinoma .b 1756 to 1863 1 to 106       106/107
(99 %)
3 diff
(97.2 %id)
TI_149284585   .b 1777 to 2462 769 to 81   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 689/1105
(62 %)
13 diff
(98.9 %id)
BM999757 Fibrosarcoma .b 1780 to 2462 701 to 19   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 683/683
(100 %)
2 diff
(99.8 %id)
BU631014 cell lines, Chondrosarcoma .b 1783 to 2469 698 to 12   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 687/687
(100 %)
0 diff
(100 %id)
CB241302 Human Lung Epithelial cells, lung .b 1784 to 2462 697 to 19   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 679/681
(99 %)
2 diff
(99.8 %id)
TI_154100300   .b 1785 to 2470 783 to 98   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 686/687
(99 %)
3 diff
(99.6 %id)
CA441231 Fibrosarcoma .b 1805 to 2470 676 to 11   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 666/666
(100 %)
3 diff
(99.6 %id)
TI_151702812   .b 1825 to 2468 744 to 96       649/1373
(47 %)
0 diff
(100 %id)
TI_149308318   .b 1834 to 2462 710 to 82   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 629/992
(63 %)
0 diff
(100 %id)
BU687166 lung, Primary Lung Epithelial Cells .b 1834 to 2462 647 to 19   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 629/643
(97 %)
0 diff
(100 %id)
BQ003773 Chondrosarcoma, Left Pelvis .b 1836 to 2470 653 to 19   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 635/635
(100 %)
2 diff
(99.7 %id)
BU678898 lung, Primary Lung Epithelial Cells .b 1870 to 2470 611 to 11   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 601/601
(100 %)
5 diff
(99.2 %id)
BP226769   .b 1871 to 2435 1 to 564       564/564
(100 %)
13 diff
(97.7 %id)
BU680602 lung, Primary Lung Epithelial Cells .b 1873 to 2462 609 to 19   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 591/591
(100 %)
1 diff
(99.9 %id)
AI760059 pooled .b 1883 to 2468 588 to 1       588/588
(100 %)
7 diff
(98.9 %id)
FN095741 breast carcinoma .b 1907 to 2016 1 to 114       114/116
(98 %)
4 diff
(96.6 %id)
BE003841 breast_normal .b 1922 to 2172 1 to 250       250/258
(96 %)
3 diff
(98.9 %id)
BM126654 Islets of Langerhans, Pancreas .b 1924 to 2469 554 to 9       546/554
(98 %)
0 diff
(100 %id)
BM841808 lymph node, stomach .b 1940 to 2461 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
AI669581 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1952 to 2462 526 to 16   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 511/511
(100 %)
0 diff
(100 %id)
C03115 heart .b 1954 to 2228 1 to 276       276/276
(100 %)
9 diff
(96.8 %id)
AW517672 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1958 to 2462 505 to 1       505/505
(100 %)
0 diff
(100 %id)
AI598267 adenocarcinoma, Pancreas .b 1963 to 2462 519 to 20   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 500/500
(100 %)
0 diff
(100 %id)
AV718867 corresponding non cancerous liver tissue .b 1973 to 2449 477 to 1     Submitted on the opposite strand 477/477
(100 %)
1 diff
(99.8 %id)
AV720484 corresponding non cancerous liver tissue .b 1975 to 2445 471 to 1     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
AW769244 colon, moderately-differentiated adenocarcinoma .b 1976 to 2462 487 to 1       487/487
(100 %)
0 diff
(100 %id)
AV720485 corresponding non cancerous liver tissue .b 1977 to 2451 475 to 1     Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
AW081457 colon, moderately differentiated adenocarcinoma .b 1977 to 2469 520 to 28   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 493/493
(100 %)
9 diff
(98.2 %id)
BE464825 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 1977 to 2462 496 to 11   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 486/486
(100 %)
0 diff
(100 %id)
BE003849 breast_normal .b 1978 to 2172 200 to 9     Submitted on the opposite strand 192/200
(96 %)
0 diff
(100 %id)
BE003850 breast_normal .b 1978 to 2172 202 to 9     Submitted on the opposite strand 194/202
(96 %)
0 diff
(100 %id)
BE003851 breast_normal .b 1978 to 2172 197 to 6     Submitted on the opposite strand 192/197
(97 %)
0 diff
(100 %id)
AI031901 parathyroid gland, parathyroid tumor .b 1991 to 2468 482 to 4       479/482
(99 %)
0 diff
(100 %id)
AA873292 2 pooled tumors (clear cell type), Kidney .b 1993 to 2471 482 to 4   tiling clone,   479/482
(99 %)
0 diff
(100 %id)
AI560158 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2005 to 2469 475 to 12   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 464/464
(100 %)
1 diff
(99.8 %id)
AW090551 brain, tumor, 5 pooled (see description) .b 2005 to 2462 461 to 2       460/461
(99 %)
0 diff
(100 %id)
AW074547 colon, juvenile granulosa tumor .b 2007 to 2469 460 to 1       460/460
(100 %)
3 diff
(99.4 %id)
BE048958 Kidney .b 2007 to 2468 465 to 4       462/465
(99 %)
0 diff
(100 %id)
AI635695 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2012 to 2469 458 to 1       458/458
(100 %)
0 diff
(100 %id)
CB143974 Liver .b 2016 to 2470 474 to 20   AAA Submitted on the opposite strand 455/455
(100 %)
0 diff
(100 %id)
AW001685 Kidney .b 2019 to 2469 455 to 6       450/455
(98 %)
0 diff
(100 %id)
AI985385 Kidney .b 2036 to 2469 439 to 6       434/439
(98 %)
0 diff
(100 %id)
AI598106 adenocarcinoma, Pancreas .b 2043 to 2462 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AA831878 germinal center B cell .b 2045 to 2470 445 to 21   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 425/425
(100 %)
1 diff
(99.8 %id)
AA598778   .b 2057 to 2463 407 to 1       407/407
(100 %)
0 diff
(100 %id)
H21607 breast .b 2065 to 2430 1 to 372       372/407
(91 %)
10 diff
(97.6 %id)
AI356988 lymph node, lymphoma, follicular mixed small and largecell .b 2077 to 2470 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI888542 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2097 to 2471 376 to 2       375/376
(99 %)
0 diff
(100 %id)
AI695353 Kidney .b 2116 to 2366 251 to 1       251/251
(100 %)
0 diff
(100 %id)
BE716325 head_neck .b 2128 to 2434 1 to 306       306/320
(95 %)
9 diff
(97.2 %id)
BG576612 breast, mammary adenocarcinoma, cell line .b 2135 to 2462 1 to 328   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 328/328
(100 %)
0 diff
(100 %id)
FN138324 breast carcinoma .b 2140 to 2255 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
BU789090 insulinoma, Pancreas .b 2154 to 2462 324 to 16   AAA Submitted on the opposite strand 309/452
(68 %)
1 diff
(99.8 %id)
AA669965 bone marrow stroma .b 2160 to 2462 303 to 1       303/303
(100 %)
0 diff
(100 %id)
AI933914 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2161 to 2470 336 to 27   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 310/310
(100 %)
2 diff
(99.4 %id)
BE349623 malignant melanoma, metastatic to lymphnode, skin .b 2175 to 2470 320 to 25   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 296/296
(100 %)
2 diff
(99.4 %id)
BM818793 stomach .b 2271 to 2462 1 to 192   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 192/192
(100 %)
0 diff
(100 %id)
FN082515 breast carcinoma .b 2296 to 2402 103 to 1     Submitted on the opposite strand 103/103
(100 %)
3 diff
(97.1 %id)
DB175775 kidney, tumor tissue .c 1 to 489 9 to 496   tiling clone, capped   495/495
(100 %)
2 diff
(99.6 %id)
BF476163 Kidney .c 436 to 1043 608 to 1   tiling clone,   608/608
(100 %)
7 diff
(98.9 %id)
AV751902 Pituitary .d 1 to 642 1 to 638   tiling clone,   598/730
(81 %)
36 diff
(95.1 %id)
DA360291 subthalamic nucleus .d 131 to 670 2 to 542   tiling clone, capped   541/541
(100 %)
3 diff
(99.5 %id)
AL601488   .d 332 to 1182 1 to 848   tiling clone,   848/853
(99 %)
10 diff
(98.9 %id)
BX433374 adult brain, brain .d 344 to 1153 803 to 1   tiling clone,   803/881
(91 %)
11 diff
(98.8 %id)
TI_57218688   .d 354 to 1207 33 to 891 L41S N42*     855/891
(95 %)
19 diff
(97.9 %id)
BI755533 brain .d 357 to 1207 1 to 856 L41S N42* tiling clone,   852/856
(99 %)
13 diff
(98.5 %id)
DA605173   .e 1 to 511 2 to 514 C26L K27Q K28E E29R G30R ... tiling clone, capped   513/513
(100 %)
4 diff
(99.3 %id)
BC028028 Blood, adult leukocytes .f-u 1 to 1541 1 to 1570 T61P S62L W63F G64S C65A ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 1570/1570
(100 %)
8 diff
(99.5 %id)
BI909787 leukocyte .f-u 1 to 891 1 to 928 A9C A49G L50S T52V L53F ... tiling clone, available from MGC,   928/928
(100 %)
27 diff
(97.1 %id)
TI_57237920   .f-u 1 to 891 30 to 957 A9C A49G L50S T52V L53F ...     928/957
(96 %)
6 diff
(99.4 %id)
BQ447225 Knee, Osteoarthritic Cartilage .f-u 668 to 1403 754 to 19   AAA   736/736
(100 %)
0 diff
(100 %id)
FN098200 breast carcinoma .f-u 845 to 930 1 to 87       87/88
(98 %)
2 diff
(97.8 %id)
CR610191 thymus .g 1 to 1042 2 to 1043 exact tiling clone,   1043/1043
(100 %)
0 diff
(100 %id)
DA318227 hippocampus .h 1 to 560 2 to 563 V61C V62C E63R N64E I65Y ... tiling clone, capped   562/566
(99 %)
6 diff
(99.0 %id)
BE176157 head_neck .h 233 to 712 485 to 7   tiling clone, Submitted on the opposite strand 479/485
(98 %)
0 diff
(100 %id)
CD698424 normal nasopharynx .i 1 to 301 17 to 317 K28E I72L tiling clone,   302/317
(95 %)
12 diff
(96.3 %id)
BG204955   .j 1 to 670 1 to 669 F40X I49X D50* tiling clone,   669/858
(77 %)
5 diff
(99.5 %id)
AV660665 corresponding non cancerous liver tissue .k-u 1 to 437 1 to 437 exact tiling clone, Submitted on the opposite strand 437/437
(100 %)
0 diff
(100 %id)
AV660736 corresponding non cancerous liver tissue .k-u 1 to 437 1 to 437 exact   Submitted on the opposite strand 437/437
(100 %)
1 diff
(99.8 %id)
CR613624 fetal brain .k-u 181 to 1991 1 to 1811   tiling clone,   1811/1811
(100 %)
0 diff
(100 %id)
BX411347 brain, fetal brain .k-u 286 to 1165 874 to 1       874/883
(98 %)
33 diff
(96.3 %id)
CD356870 Blood vessels - aorta, basilar and artery .k-u 499 to 1064 1 to 585       585/738
(79 %)
33 diff
(95.6 %id)
AL568181 brain, fetal brain .k-u 1004 to 1991 988 to 1       988/994
(99 %)
17 diff
(98.3 %id)
BX455680.
matches multiple genes
brain, fetal brain .k-u 1138 to 1984 857 to 12     also hits gene C5orf13 846/857
(98 %)
0 diff
(100 %id)
BX486077   .k-u 1663 to 2011 377 to 28   tiling clone, Submitted on the opposite strand 350/377
(92 %)
0 diff
(100 %id)
BU567733 testis .l-u 1 to 837 1 to 835 H33Y T34I H35* tiling clone,   835/843
(99 %)
9 diff
(99.0 %id)
DB177074 kidney, tumor tissue .m 1 to 546 2 to 547 exact tiling clone, capped   546/546
(100 %)
1 diff
(99.9 %id)
AL603323 human skeletal muscle Gene STXBP3, variant not shown              
BX501268 Liver Gene STXBP3, variant not shown              
AV660735 corresponding non cancerous liver tissue Gene STXBP3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV685999 hepatocellular carcinoma Gene STXBP3, variant not shown         Suspected internal deletion, this clone was ignored    
AV688185 hepatocellular carcinoma Gene STXBP3, variant not shown         Suspected internal deletion, this clone was ignored    
DB312848 thalamus Gene STXBP3, variant not shown              
DA418343 thalamus Gene STXBP3, variant not shown       capped      
BX436878 thymus Gene STXBP3, variant not shown       fully sequenced, This clone was ignored    
BX436879 thymus Gene STXBP3, variant not shown       fully sequenced, This clone was ignored    
BF959897 nervous_normal Gene STXBP3, variant not shown              
GD151125   Gene STXBP3, variant not shown       AAA      
CV391214 nervous_normal Gene STXBP3, variant not shown              
DA509908 brain Gene STXBP3, variant not shown       capped This clone was ignored    
H49663 brain Gene STXBP3, variant not shown              
AW130533 poorly differentiated adenocarcinoma withsignet ring cell features, stomach Gene STXBP3, variant not shown       AAA      
BQ028131 mixed Gene STXBP3, variant not shown       AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base)    
BG723474 testis Gene STXBP3, variant not shown         This clone was ignored    
BU853438 testis Gene STXBP3, variant not shown         Suspected internal deletion, this clone was ignored    
BU854416 testis Gene STXBP3, variant not shown         Suspected internal deletion, this clone was ignored    
DB140265 thymus Gene STXBP3, variant not shown       capped      
DB345316 thymus Gene STXBP3, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k-u, .l-u, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI